Injectables refer to drug delivery system which acts as an alternative to oral drugs. As injectables are rapidly inserted into the human body using a syringe, they bypass the first-pass metabolism. The global generic injectables market is likely to register a CAGR of over 8.7% with an incremental growth of USD 49 billion during the forecast period 2022-2028.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global generic injectables market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the generic injectables industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, route of administration, application, and region. The global market for generic injectables can be segmented by product: large molecule, small molecule. Generic injectables market is further segmented by route of administration: intravenous (IV) generic injectables, intramuscular (IM) generic injectables, subcutaneous (SC) generic injectables, others. Based on application, the generic injectables market is segmented into: oncology, infectious diseases, cardiology, diabetes, immunology, others. On the basis of region, the generic injectables market also can be divided into: Asia Pacific, Europe, North America, Rest of the World (RoW).

By product:
– large molecule
– small molecule

By route of administration:
– intravenous (IV) generic injectables
– intramuscular (IM) generic injectables
– subcutaneous (SC) generic injectables
– others

By application:
– oncology
– infectious diseases
– cardiology
– diabetes
– immunology
– others

By region:
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)

The report also provides analysis of the key companies of the industry and their detailed company profiles including AstraZeneca plc, Baxter International, Inc., Dr. Reddy’s Laboratories Ltd., Fresenius SE & Co. KGaA, Hikma Pharmaceuticals plc, Lupin Limited, Merck & Co., Inc., Mylan N.V., Pfizer, Inc, among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report
– To analyze and forecast the market size of the global generic injectables market.
– To classify and forecast the global generic injectables market based on product, route of administration, application, region.
– To identify drivers and challenges for the global generic injectables market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global generic injectables market.
– To identify and analyze the profile of leading players operating in the global generic injectables market.

Why Choose This Report
– Gain a reliable outlook of the global generic injectables market forecasts from 2022 to 2028 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.